HB 1550 Hawaii House · 2026 Regular Session

RELATING TO HEALTH.

HB 1550 removes drug testing products (like home kits or workplace screening tools) from the legal definition of "drug paraphernalia" under the Uniform Controlled Substances Act. This change directly affects businesses that sell these products and individuals who use them, as they will no longer face penalties for possessing them under current drug paraphernalia laws. The bill achieves this by amending the statute to specifically exclude these testing products from the prohibited category. The policy change clarifies legal status without altering broader drug control provisions.
Bill status passed both 4 of 5 stages cleared
Introduction
Jan 2026
Committee Review
May 2026
House Passage
Mar 2026
Senate Passage
Apr 2026
Governor
Introduced Jan 15, 2026 Last action May 6, 2026
Maddy AI version diff · 5 comparisons

What changed between versions

HB1550_SD1 HB1550_SD2 · 3 edits
MINOR
This bill updates the legislative metadata to reflect a new sponsor and revised dates, while substantively expanding the definition of drug paraphernalia to include diluents and adulterants. The most significant policy change is the extension of the bill's effective date to March 22, 2075, providing a much longer implementation timeline than the original version.
Scope change
The bill's scope was expanded by explicitly including diluents and adulterants (such as quinine hydrochloride and mannitol) in the definition of drug paraphernalia, whereas the previous version excluded these items.
TIMELINE

The effective date of the Act was changed from immediate approval to March 22, 2075.

DEFINITION

The definition of drug paraphernalia was modified to include diluents and adulterants used in cutting controlled substances.

TECHNICAL

The bill sponsor was changed from Fredrick Akau to Blake Anderson, and associated metadata dates and numbers were updated.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
40
Key actions
14
Committee
16
Amendments
3
May 6, 2026
Committee
Recommitted to Conference committee as amended in CD 1 with none voting no and Representative(s) Alcos excused.
lower
Apr 29, 2026
Introduced
48 Hrs. Notice (as amended CD 1) 05-06-26
upper
Apr 29, 2026
Upper · Passed
Reported from Conference Committee as amended CD 1 (Conf. Com. Rep. No. 80-26).
upper
Apr 29, 2026
Lower · Passed
Reported from Conference Committee (Conf Com. Rep. No. 80-26) as amended in (CD 1).
lower
Apr 29, 2026
Lower · Passed
The Conference Committee recommends that the measure be Passed, with Amendments. The votes were as follows: 4 Ayes: Representative(s) Takayama, Tarnas, Keohokapu-Lee Loy; Ayes with reservations: Representative(s) Garcia; 0 Noes: none; and 0 Excused: none.
lower
Apr 29, 2026
Upper · Passed
The Conference committee recommends that the measure be PASSED, WITH AMENDMENTS. The votes of the Senate Conference Managers were as follows: 3 Aye(s): Senator(s) San Buenaventura, Rhoads, McKelvey; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
upper
Apr 28, 2026
Upper · Passed
Conference committee meeting scheduled for 04-29-26 3:45PM; CR 329.
upper
Apr 16, 2026
Amended
House disagrees with Senate amendment (s).
lower
Apr 14, 2026
Introduced
Returned from Senate (Sen. Com. No. 584) in amended form (SD 2).
lower
Apr 14, 2026
Upper · Passed
Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.
upper
Apr 1, 2026
Upper · Passed
The committee(s) on JDC recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in JDC were as follows: 4 Aye(s): Senator(s) Rhoads, Chang, San Buenaventura, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Gabbard.
upper
Mar 30, 2026
Upper · Passed
The committee(s) on JDC will hold a public decision making on 04-01-26 10:40AM; Conference Room 016 & Videoconference.
upper
Mar 25, 2026
Upper · Passed
Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.
upper
Mar 25, 2026
Committee
Reported from HHS (Stand. Com. Rep. No. 3191) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.
upper
Mar 20, 2026
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) McKelvey.
upper
Mar 17, 2026
Upper · Passed
The committee(s) on HHS has scheduled a public hearing on 03-20-26 1:00PM; Conference Room 225 & Videoconference.
upper
Mar 12, 2026
Committee
Referred to HHS, JDC.
upper
Mar 12, 2026
Introduced
Received from House (Hse. Com. No. 243).
upper
Mar 10, 2026
Lower · Passed
Passed Third Reading as amended in HD 2 with Representative(s) Garcia, Kila voting aye with reservations; Representative(s) Pierick voting no (1) and none excused (0). Transmitted to Senate.
lower
Feb 25, 2026
Lower · Passed
The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Tarnas, Poepoe, Cochran, Hashem, Kahaloa, Sayama, Takayama, Garcia, Shimizu; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Belatti.
lower
Feb 18, 2026
Committee
Reported from HLT (Stand. Com. Rep. No. 359-26) as amended in HD 1, recommending passage on Second Reading and referral to JHA.
lower
Feb 13, 2026
Lower · Passed
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Hartsfield, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
lower
Jan 26, 2026
Committee
Referred to HLT, JHA, referral sheet 1
lower
Jan 21, 2026
Introduced
Introduced and Pass First Reading.
lower
Jan 15, 2026
Introduced
Prefiled.
lower
14 primary · 1 co-sponsor

Sponsors